A previous study has provided that LKB1 loss triggers complex changes in tumor microenvironment, suggesting a potential role in the response to anti-angiogenic treatment.[32] A number of articles have reported the prognostic value of LKB1 expression in tumors among patients with lung cancer and the results remain controversial. This evidence concerns the gene STK11 and lung carcinoma.